Macular sensitivity after half-dose verteporfin photodynamic therapy in central serous chorioretinopathy
暂无分享,去创建一个
S. Sinawat | T. Ratanapakorn | Y. Yospaiboon | Chavakij Bhoomibunchoo | T. Sanguansak | Prapapan Pitujaturont
[1] P. Jirarattanasopa,et al. Photoreceptor disruption in central serous chorioretinopathy treated by half-dose photodynamic therapy , 2013, Clinical ophthalmology.
[2] Y. Mizutani,et al. Correlation of integrity of cone outer segment tips line with retinal sensitivity after half-dose photodynamic therapy for chronic central serous chorioretinopathy. , 2012, American journal of ophthalmology.
[3] K. Fujita,et al. RETINAL SENSITIVITY AFTER PHOTODYNAMIC THERAPY WITH HALF-DOSE VERTEPORFIN FOR CHRONIC CENTRAL SEROUS CHORIORETINOPATHY: Short-Term Results , 2011, Retina.
[4] H. Ozdemir,et al. Microperimetric changes after photodynamic therapy for central serous chorioretinopathy. , 2011, American journal of ophthalmology.
[5] R. Jack,et al. Photodynamic Therapy Rescue for Subretinal Fluid Exacerbation After Focal Laser Treatment in Idiopathic Central Serous Chorioretinopathy , 2011, The open ophthalmology journal.
[6] H. Iijima,et al. Retinal thickness and perimetric sensitivity in central serous chorioretinopathy , 2010, Japanese Journal of Ophthalmology.
[7] R. Spaide,et al. Subfoveal choroidal thickness after treatment of central serous chorioretinopathy. , 2010, Ophthalmology.
[8] J. Ruiz-Moreno,et al. Photodynamic therapy for chronic central serous chorioretinopathy , 2009, Acta ophthalmologica.
[9] K. Schaal,et al. Intravitreal Bevacizumab for Treatment of Chronic Central Serous Chorioretinopathy , 2009, European journal of ophthalmology.
[10] T. Lai,et al. Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: one-year results of a randomized controlled trial. , 2008, Ophthalmology.
[11] H. Ozdemir,et al. Macular Sensitivity in Eyes with Central Serous Chorioretinopathy , 2008, European journal of ophthalmology.
[12] Masanori Hangai,et al. Retinal sensitivity measured with the micro perimeter 1 after resolution of central serous chorioretinopathy. , 2008, American journal of ophthalmology.
[13] H. Ozdemir,et al. Assessment of macular function by microperimetry in unilateral resolved central serous chorioretinopathy , 2008, Eye.
[14] M. Colucciello. Choroidal neovascularization complicating photodynamic therapy for central serous retinopathy. , 2006, Retina.
[15] Michael Larsen,et al. Clinical characteristics of subretinal deposits in central serous chorioretinopathy. , 2005, Acta ophthalmologica Scandinavica.
[16] Klaus Rohrschneider,et al. Fundus perimetry with the Micro Perimeter 1 in normal individuals: comparison with conventional threshold perimetry. , 2005, Ophthalmology.
[17] J. Català Mora,et al. Photodynamic Therapy for Chronic Central Serous Chorioretinopathy , 2004 .
[18] J. Castro-Correia,et al. Long-term follow-up of central serous retinopathy in 150 patients , 2004, Documenta Ophthalmologica.
[19] A. Mudun,et al. Laser photocoagulation for persistent central serous retinopathy: results of long-term follow-up. , 1997, Ophthalmology.